Form D · Pharmaceuticals
Zeno Pharma, LLC
San Diego, CA · CIK 0001725160
Offering snapshot reported Sep 5, 2019 · SEC filing
- Reported sold
- Yet to sell Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 5, 2019 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Dec 19, 2017 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3.63M (estimated)
- Finders' fees
- $0
- Form D file number
- 021-348039
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| BFC Group Ltd. | None | |
| Cowen and Company, LLC | 7616 |
Source: Form D, filed Sep 5, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cam Gallagher | Director, Executive |
| David Goel | Director |
| Anthony Y. Sun, M.D. | Director, Executive |
| Karan Takhar | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
10835 Road To The Cure, Suite 205
San Diego, CA, 92121
San Diego, CA, 92121